Intravenous Versus Subcutaneous Dosing of Epoetin: A Review of the Literature
- 1 August 1993
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 22 (2) , 23-31
- https://doi.org/10.1016/0272-6386(93)70178-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Anemia of Chronic Inflammatory Arthritides: Treatment with Recombinant Human ErythropoietinPublished by S. Karger AG ,2015
- Effect of Continuous Ambulatory Peritoneal Dialysis on Blood Pressure ControlAmerican Journal of Kidney Diseases, 1993
- Comparison of Subcutaneous and Intravenous Recombinant Human Erythropoietin for Anemia in Hemodialysis Patients with Significant Comorbid DiseaseAmerican Journal of Nephrology, 1992
- Assessment of pain after subcutaneous injection of erythropoietin in patients receiving haemodialysis.BMJ, 1991
- Efficacy Comparison of Intravenous and Subcutaneous Recombinant Human Erythropoietin Administration in Hemodialysis PatientsPublished by S. Karger AG ,1990
- Pharmacokinetics of Recombinant Human Erythropoietin after SC Administration and in Long-Term IV Treatment in Patients on Maintenance HemodialysisPublished by S. Karger AG ,1988
- Pharmacokinetics of Intravenous, Intraperitoneal, and Subcutaneous Recombinant Erythropoietin in Patients on CAPDPublished by S. Karger AG ,1988
- Variations of Recombinant Human Erythropoietin Application in Hemodialysis PatientsPublished by S. Karger AG ,1988
- Experience with Daily Self-Administered Subcutaneous ErythropoietinPublished by S. Karger AG ,1988
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987